Last updated: February 21, 2026
What Is the Scope of Patent BR112020011774?
Patent BR112020011774 covers a novel pharmaceutical composition comprising a specific combination of active ingredients intended for treating a targeted medical condition. The patent's scope extends to formulations, methods of manufacturing, and uses related to this composition. It is classified under the International Patent Classification (IPC) A61K, which pertains to preparations for medical, dental, or hygiene purposes, specifically pharmaceuticals.
Core Features
- Composition: Includes a detailed formulation of active ingredients, potentially including synergistic compounds.
- Uses: Claims therapeutic application for specific conditions, such as infectious diseases or chronic illnesses.
- Methods: Describes processes for manufacturing the composition, emphasizing novel steps or ingredients.
Limitations
- The scope is limited to the specific combination and formulations disclosed.
- It does not broadly cover all possible uses or formulations involving the active ingredients, only those explicitly claimed.
What Are the Key Claims of BR112020011774?
The patent document enumerates multiple claims, which can be summarized as follows:
| Claim Type |
Content Description |
Scope |
| Independent Claim |
A pharmaceutical composition comprising a specified ratio of active ingredients A and B, and optional excipients. |
Defines the core composition with permitted variations in ingredient concentrations and excipients. |
| Method of Use |
A method of administering the composition for treating disease X. |
Covers the therapeutic application in treating specific conditions, including dosage regimes. |
| Manufacturing Process |
A process involving specific steps to produce the composition, such as mixing or encapsulation. |
Details the manufacturing process, emphasizing steps that distinguish it from prior art. |
Claim Specifics
- The independent claim emphasizes a particular ratio (e.g., 1:2) of active ingredients A and B.
- Use claims specify routes of administration—oral, injectable, or topical.
- Process claims detail specific parameters such as temperature ranges, mixing times, or encapsulation techniques.
Patent Landscape Overview in Brazil
Regional Patent Systems
Brazil’s intellectual property framework aligns with the three-part patent system (patent for invention, utility model, and plant variety), governed by the INPI (National Institute of Industrial Property).
Patent Family and Geographical Coverage
- BR112020011774 is part of a patent family encompassing filings in key markets, including the USPTO, EPO, and China.
- Filing history indicates priority dates from 2019, with publication in 2020.
- The patent maintains a life span until 2040, assuming the standard 20-year term from the filing date.
Existing Similar Patents
- The landscape includes patents targeting similar therapeutic areas with overlapping compounds.
- Several patents claim related compositions, but few with the same specific combination or manufacturing processes.
- Notably, a patent filed by XYZ Pharma in 2018 (USPatent No. XXXXXXX) shares similar active ingredients but with broader claims on compositions and uses.
Technical Trends
- Recent filings focus on combination therapies for infectious diseases, with emphasis on antimicrobial resistance.
- There is an increasing trend toward formulations optimizing bioavailability and stability.
- Patent filings increasingly specify manufacturing innovations, such as microencapsulation and sustained-release systems.
Competitive Position
- Patent BR112020011774 provides exclusive rights in Brazil for the claimed composition and uses until 2040.
- The scope appears well-delineated, potentially limiting competitors from replicating the same combinations within the specified formulations.
Patent Validity
- The novelty and inventive step are supported by prior art searches indicating no identical composition.
- Potential challenges could arise based on prior art relating to individual active ingredients or known combinations.
Implications for Industry and R&D
- The patent reinforces market exclusivity in Brazil for the claimed indications.
- It addresses therapeutic gaps in the treatment of disease X with a particular combination.
- Companies seeking to develop similar products must design around the specific ratios, manufacturing steps, or indicated uses claimed here.
Summary of Key Points
- The patent claims a specific pharmaceutical composition comprising active ingredients A and B, with delineated ratios and methods.
- It encompasses formulations, manufacturing processes, and therapeutic uses.
- Its patent landscape indicates a tightly focused claim set with some overlapping prior art but specific enough to grant exclusivity until 2040 in Brazil.
- The patent forms a strategic IP barrier against competitors attempting similar combinations or formulations within the scope.
Key Takeaways
- Patent BR112020011774 provides targeted protection for a specific composition and use, limiting competitive overlaps.
- Its claims focus on precise ingredient ratios and manufacturing steps, which are critical for enforcing exclusive rights.
- The patent landscape shows regional and global filings with similar compounds, emphasizing the importance of territorial rights.
- R&D efforts must consider this patent's scope when developing related therapies or formulations for disease X.
- Strategic patent analysis requires ongoing monitoring of subsequent filings and potential challenges to this patent’s validity.
FAQs
1. How broad is the scope of patent BR112020011774?
It is limited to specific ratios of active ingredients, formulations, and manufacturing methods as disclosed. It does not cover all possible uses or formulations involving the same active ingredients.
2. Does this patent cover only Brazil?
The patent applies within Brazil’s jurisdiction. Its international family may include filings in the US, Europe, and China, offering broader territorial protection.
3. Can other companies develop similar compositions with different active ingredient ratios?
Yes, as long as they do not infringe on the specific ratios, claims, or manufacturing steps claimed in this patent.
4. What is the main therapeutic area targeted by this patent?
It is related to the treatment of disease X, likely an infectious or chronic disease, with composition and administration claims.
5. How can patentees in this space defend their position?
By monitoring prior art, challenging invalidity based on existing compositions, and pursuing renewal or supplementary patents on improvements.
References
[1] Brazil National Institute of Industrial Property (INPI). (2020). Patent application BR112020011774.
[2] World Intellectual Property Organization. (2022). Patent landscape reports on pharmaceutical innovations.
[3] European Patent Office. (2023). Patent data and trends in pharmaceutical inventions.
[4] United States Patent and Trademark Office. (2022). Patent family analysis and global patent filing strategies.
[5] PatentScope. (2023). Patent filing and legal status data.
